Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1993
10/06/1993CN1022319C Method for prepn. of tetralin derivs
10/05/1993US5250679 Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
10/05/1993US5250544 New piperidine tetrahydropyridine and pyrrolidine compounds
10/05/1993US5250540 Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use in medicaments
10/05/1993US5250539 5-alpha reductase inhibitors; administer as therapy for benign prostatic hyperplasia, hirsutism and acne
10/05/1993US5250519 Non-anticoagulant heparin derivatives
10/05/1993CA2093305A1 Peptides with modifications at the n terminus
10/05/1993CA1322761C Organogermanium compounds and process for producing the same
10/05/1993CA1322752C Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same
10/05/1993CA1322719C Activator for osteoblast
10/05/1993CA1322713C Compositions and methods for modulating the effect of tnf and il-1
10/04/1993CA2093262A1 Anti-skin rash preparation
10/03/1993CA2093165A1 Formulated medicines and processed foods to potentiate host defense activity, and methods for treatment of infectious diseases
10/02/1993CA2092886A1 Cycloalkyl- and heterocyclyl-substituted imidazolylpropenoic acid derivatives
10/02/1993CA2092852A1 Imidazole derivatives, their method of preparation and their application in therapeutic
09/1993
09/30/1993WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993WO1993019168A1 Reconstituted cartilage tissue
09/30/1993WO1993019085A1 Novel antler-derived bone growth factors
09/30/1993WO1993019063A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
09/30/1993WO1993019046A1 Novel sulfonamide fibrinogen receptor antagonists
09/30/1993WO1993019044A1 Novel vitamin d analogues
09/30/1993WO1993019036A1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
09/30/1993WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders
09/30/1993WO1993018774A1 Use if estriol for treating climacteric osteoporosis
09/30/1993WO1993018768A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
09/30/1993WO1993018762A2 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/30/1993WO1993018760A1 Use of transglutaminase inhibitor for the treatment of scar tissue
09/30/1993WO1993016099A3 Dna sequences encoding novel growth/differentiation factors
09/30/1993WO1993015203A3 Polypeptides with fibronectin binding sites as modulators for matrix assembly
09/30/1993CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993CA2132219A1 Novel antler-derived bone growth factors
09/30/1993CA2132209A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
09/30/1993CA2132102A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
09/30/1993CA2130195A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
09/30/1993CA2120703A1 Novel vitamin d analogues
09/29/1993EP0562956A1 Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them
09/29/1993EP0562936A1 Imidazolines N-substituted by a biphenylmethyl group, their preparation, the pharmaceutical compositions containing them
09/29/1993EP0562508A2 Protein with bone formation ability and process for its production
09/29/1993EP0562261A2 Sulphonylbenzyl substituted imidazoles
09/29/1993EP0561979A1 Use of angiotensin ii antagonists in the treatment of angina pectoris
09/29/1993EP0561977A1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke
09/29/1993EP0561965A1 Enhancement of musculature in animals
09/29/1993EP0561948A1 Phosphonic acid derivatives useful as antiinflammatory agents.
09/29/1993EP0561939A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy
09/29/1993EP0561910A1 Pharmaceuticals
09/29/1993EP0561905A1 Use of angiotensin ii receptor antagonists in the treatment of macular degeneration
09/29/1993EP0561901A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
09/29/1993EP0561896A1 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function
09/29/1993EP0561895A1 Use of angiotensin ii receptor antagonists in the prevention of restinosis
09/29/1993EP0561878A1 Use of angiotensin ii antagonist in the treatment of infarction
09/29/1993EP0561877A1 Compounds and compositions which inhibit bone resorption
09/29/1993EP0387252B1 Lubricant composition for rheumatism
09/29/1993CN1076696A Pharmaceutical compounds
09/28/1993US5248785 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
09/28/1993US5248697 For treatment of radiation associated oxidative damage in tissue
09/28/1993US5248684 Certain 2-oxo-quinoline carboxylates or corresponding carboxamides useful as anti-emetics and suppressants of migraine
09/28/1993US5248681 Antiinflammatory agents
09/28/1993US5248680 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions
09/28/1993CA2092768A1 Protein with bone formation ability and process for its production
09/28/1993CA1322531C Phenolic thioethers as inhibitors of 5-lipoxygenase
09/22/1993EP0561597A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them
09/22/1993EP0561357A1 Pharmaceutical composition comprising a potassium-channel-opener and an antagonist of angiotensin-II receptors
09/22/1993EP0561296A1 Cyclic aminomethylene bisphosphonate derivatives
09/22/1993EP0561252A1 2-Oxoquinoline derivatives as angiotensin II antagonists
09/22/1993EP0561175A1 Pyrimidine derivatives and pharmaceutical compostions containing them
09/22/1993EP0561166A1 Aerosol compositions containing compound D-18024 and its analogs
09/22/1993EP0560937A1 Pharmaceutical compositions
09/22/1993EP0526578A4 Composition and method for topical treatment of damaged or diseased tissue
09/22/1993EP0477178B1 Therapeutic composition and kit for the treatment of rhumatoid polyarthritis
09/22/1993CN1076443A Substituted phenylacetamides
09/22/1993CN1076441A Process for preparing fibrinogen receptor antagonists
09/22/1993CN1076439A New compounds
09/22/1993CN1076358A Methods and compositions for reducing multi-drug resistance
09/22/1993CN1076357A Pharmaceutical composition
09/22/1993CN1022187C Method for preparation of tricyclic compounds
09/22/1993CN1022184C Process for preparing (1 H-imidzol-1-ylmethyl) substituted benzotriazole derivatives
09/21/1993US5247102 Cyclization of a resorcinol derivative with ethyl orthoformate in the presence of a base
09/21/1993US5246971 Method of inhibiting nitric oxide formation
09/21/1993US5246966 Substituted alkenoic acid and its derivatives
09/21/1993US5246956 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans having antithromboxane a2 activity
09/21/1993US5246952 Heteroarylmethylbenzenes
09/21/1993US5246950 Thioformamide derivatives
09/21/1993US5246945 Piperidine derivatives
09/21/1993US5246940 Substituted n-biphenylyl lactams
09/21/1993US5246700 In patients suffering from malignant tumors, interleukin-4
09/21/1993CA2091942A1 Pharmaceutical composition
09/21/1993CA1322374C Substituted di-t-butylphenols
09/19/1993CA2091829A1 Cyclic aminomethylene bisphosphonate derivatives
09/19/1993CA2091214A1 Pyrimidine derivatives
09/18/1993CA2091713A1 Dosage aerosols containing the active substance flezelastin and related structures
09/17/1993CA2092671A1 2-oxoquinoline derivatives
09/17/1993CA2091550A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them
09/16/1993WO1993018141A1 Thrombin receptor antagonists
09/16/1993WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
09/16/1993WO1993018040A1 Cyclic ketal derivatives
09/16/1993WO1993018039A1 Cyclic ketal derivatives
09/16/1993WO1993018032A1 Indole derivatives as 5-ht1 agonists
09/16/1993WO1993018030A1 Benzimidazole derivatives as angiotensin ii antagonists
09/16/1993WO1993018027A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
09/16/1993WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor
1 ... 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 ... 1564